NCT00038675 2022-01-04
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
M.D. Anderson Cancer Center
Phase NA Completed
Clinical Trials
4 trialsNCT00430066 2014-10-08
Effects of Imatinib Mesylate in Polycythemia Vera
Niguarda Hospital
Phase 2 Completed
NCT00245128 2012-01-13
Imatinib Mesylate in Treating Patients With Myelofibrosis
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT01120821 2010-05-17
Treatment of Polycythemia Vera With Gleevec
Weill Medical College of Cornell University
Phase 2 Completed